Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

VCEL – Vericel Corporation

VCEL — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

9.1

Margin Of Safety %

-20

Put/Call OI Ratio

0.2

EPS Next Q Diff

0.49

EPS Last/This Y

0.19

EPS This/Next Y

0.33

Price

45.03

Target Price

60.57

Analyst Recom

1.25

Performance Q

Upside

-64.3%

Beta

1.06

Ticker: VCEL




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13VCEL47.510.380.00554
2026-07-14VCEL46.070.380.00554
2026-07-15VCEL46.750.380.05554
2026-07-16VCEL47.790.370.17565
2026-07-17VCEL46.610.380.08566
2026-07-20VCEL45.850.771.33307
2026-07-21VCEL46.080.771.33307
2026-07-22VCEL44.630.78999.99314
2026-07-23VCEL45.040.80999.99316
2026-07-24VCEL45.10.810.60319
2026-07-27VCEL45.330.811.00327
2026-07-28VCEL46.680.811.50331
2026-07-29VCEL46.530.830.00333
2026-07-30VCEL47.550.190.33958
2026-07-31VCEL45.970.190.00968
2026-08-03VCEL45.960.190.00967
2026-08-04VCEL46.340.190.00967
2026-08-05VCEL45.310.19999.99966
2026-08-06VCEL44.760.190.14970
2026-08-07VCEL45.050.201.50974
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13VCEL47.47-100.0- 0.45
2026-07-14VCEL46.06-100.0- 0.45
2026-07-15VCEL46.74-100.0- 0.45
2026-07-16VCEL47.81-100.0- 0.45
2026-07-17VCEL46.64-100.0- 0.45
2026-07-20VCEL45.88-100.0- 0.45
2026-07-21VCEL46.13-100.0- 0.45
2026-07-22VCEL44.60-100.0- 0.45
2026-07-23VCEL45.06-100.0- 0.45
2026-07-24VCEL45.10-100.0- 0.45
2026-07-27VCEL45.31-100.0- 0.45
2026-07-28VCEL46.68-100.0- 0.45
2026-07-29VCEL46.52-100.0- 0.45
2026-07-30VCEL47.60-100.0- 0.45
2026-07-31VCEL45.97-8.0- 0.51
2026-08-03VCEL46.03-8.0- 0.51
2026-08-04VCEL46.03-8.0- 0.51
2026-08-05VCEL45.31-15.0- 0.55
2026-08-06VCEL44.72-15.0- 0.55
2026-08-07VCEL45.03-44.0- 0.52
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13VCEL-19.266.109.74
2026-07-14VCEL-19.266.109.74
2026-07-15VCEL-19.266.109.74
2026-07-16VCEL-19.266.109.74
2026-07-17VCEL-19.266.109.74
2026-07-20VCEL-19.266.319.74
2026-07-21VCEL-19.266.319.74
2026-07-22VCEL-19.266.319.74
2026-07-23VCEL-19.266.319.74
2026-07-24VCEL-19.266.319.74
2026-07-27VCEL-19.266.139.12
2026-07-28VCEL-19.266.139.12
2026-07-29VCEL-19.266.139.12
2026-07-30VCEL-19.266.139.12
2026-07-31VCEL-19.266.139.12
2026-08-03VCEL-19.695.079.10
2026-08-04VCEL-19.695.079.10
2026-08-06VCEL-20.735.079.10
2026-08-07VCEL-20.735.079.10
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

0.06

Avg. EPS Est. Next Quarter

0.53

Insider Transactions

-20.73

Institutional Transactions

5.07

Beta

1.06

Average Sales Estimate Current Quarter

77

Average Sales Estimate Next Quarter

112

Fair Value

35.98

Quality Score

87

Growth Score

92

Sentiment Score

54

Actual DrawDown %

28.5

Max Drawdown 5-Year %

-70.5

Target Price

60.57

P/E

97.56

Forward P/E

51.24

PEG

0.84

P/S

7.54

P/B

6.24

P/Free Cash Flow

37.45

EPS

0.46

Average EPS Est. Cur. Y​

0.52

EPS Next Y. (Est.)

0.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.91

Relative Volume

0.71

Return on Equity vs Sector %

-20.8

Return on Equity vs Industry %

-4.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.06

EBIT Estimation

VCEL Healthcare
$45.09
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
20/25
Volume
9/15
Valuation
14/20
TP/AR
2/10
Options
7/10
RSI
50
Range 1M
12.7%
Sup Dist
1.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
41 /100
WEAK
Momentum
5/25
Growth
20/30
Estimates
6/20
Inst/Vol
5/15
Options
5/10
EPS Yr
72.7%
52W%
77%
💎
Long-Term Value
Quality companies, undervalued
35 /100
WEAK
🔴 SELL -16.2% upside
Quality
10/30
Valuation
3/30
Growth
14/25
Stability
8/10
LT Trend
0/5
Upside
-16.2%
Quality
87
MoS
-20%
VCEL — P/E HistoricalBiotechnology
Vericel Corporation
Sector: Healthcare
Industry: Biotechnology
Employees: 398
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
VCEL

Latest News

Caricamento notizie per VCEL
stock quote shares VCEL – Vericel Corporation Stock Price stock today
news today VCEL – Vericel Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch VCEL – Vericel Corporation yahoo finance google finance
stock history VCEL – Vericel Corporation invest stock market
stock prices VCEL premarket after hours
ticker VCEL fair value insiders trading